Clinical Trial Update: Oral Glibenclamide in Preterm Infants With Hyperglycaemia (GALOP) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating oral glibenclamide to treat hyperglycemia in preterm infants; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Hyperglycemia

Drugs mentioned

• Glibenclamide (glibenclamide)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Transient; Hypoglycemia, Neonatal, Preterm | Phase 2 | Status: ACTIVE_NOT_RECRUITING